{
  "company": "mvision.ai",
  "dominant_topics": [
    14
  ],
  "topic_counts": {
    "14": 3
  },
  "topic_descriptions": {
    "14": "authored, minivision, minivision technology, panasonic, singapore"
  },
  "framing_scores": {
    "framing_ethical": 0.0,
    "framing_surveillance": 0.0,
    "framing_market": 1.0,
    "num_docs": 3
  },
  "topic_timeline": {
    "20": {
      "14": 3
    }
  },
  "sample_docs": [
    "New Partnership in the UK and Ireland 14.06.21 Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing MVision AI's high-quality, segmentation services throughout the UK and Ireland region. \"I am delighted Xiel has officially partnered with MVision, a company leading the way in AI technology and one we have followed closely for a number of years. AI is a buzz word in our sector at the moment and we are very excited about working with MVision to integrate their leading technology into Radiotherapy departments in the UK and Irelandâ€, said Jack Knight , Managing Director, Xiel Ltd This has a high impact on RT treatment because, according to Cancer Research UK , the time between the urgent referral and treatment process can take up to 62 days. Thanks to Xiel's distribution of MVision AI's segmentation software, oncologists will be able to receive consistent, cancer radiotherapy treatment planning. MVision's cutting-edge, segmentation solutions can help improve the efficiency of cancer patient's radiotherapy. MVsion's CEO and co-founder, Mahmudul Hasan, highlighted his delight in this new partnership, stating that, \"We have been working on MVision's state-of-the-art segmentation services for the last three years. A growing number of hospitals have incorporated our services into their radiation oncology departments. Radiation oncologists have found our solutions to be essential, while improving the speed of service to their patients. We look forward to doing the same for UK patients, as our breakthrough solution reaches the UK and Ireland with the help of Xiel.†If you are interested in learning more about Xiel's impactful distribution, check out their informative, company website and professional LinkedIn profile . For more information on our services, contact MVision AI c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland. Tel: +358 (0) 40 5489 229 Email: info (at) mvision.ai FOR MEDIA INQUIRES: +358 40 500 7915; pr (at) mvision.ai Prev MVision's AI segmentation service has been updated and now supports new Lung SABR protocol and MRI Male Pelvis protocol MR-only workflow Next UK Cancer Treatment Waiting Times and the Impact of the AI-Powered Tool New Partnership in the UK and Ireland 14.06.21 Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing MVision AI's high-quality, segmentation services throughout the UK and Ireland region. \"I am delighted Xiel has officially partnered with MVision, a company leading the way in AI technology and one we have followed closely for a number of years. AI is a buzz word in our sector at the moment and we are very excited about working with MVision to integrate their leading technology into Radiotherapy departments in the UK and Irelandâ€, said Jack Knight , Managing Director, Xiel Ltd This has a high impact on RT treatment because, according to Cancer Research UK , the time between the urgent referral and treatment process can take up to 62 days. Thanks to Xiel's distribution of MVision AI's segmentation software, oncologists will be able to receive consistent, cancer radiotherapy treatment planning. MVision's cutting-edge, segmentation solutions can help improve the efficiency of cancer patient's radiotherapy. MVsion's CEO and co-founder, Mahmudul Hasan, highlighted his delight in this new partnership, stating that, \"We have been working on MVision's state-of-the-art segmentation services for the last three years. A growing number of hospitals have incorporated our services into their radiation oncology departments. Radiation oncologists have found our solutions to be essential, while improving the speed of service to their patients. We look forward to doing the same for UK patients, as our breakthrough solution reaches the UK and Ireland with the help of Xiel.†If you are interested in learning more about Xiel's impactful distribution, check out their informative, company website and professional LinkedIn profile . For more information on our services, contact MVision AI c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland. Tel: +358 (0) 40 5489 229 Email: info (at) mvision.ai FOR MEDIA INQUIRES: +358 40 500 7915; pr (at) mvision.ai Prev MVision's AI segmentation service has been updated and now supports new Lung SABR protocol and MRI Male Pelvis protocol MR-only workflow Next UK Cancer Treatment Waiting Times and the Impact of the AI-Powered Tool New Partnership in the UK and Ireland Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing MVision AI's high-quality, segmentation services throughout the UK and Ireland region. \"I am delighted Xiel has officially partnered with MVision, a company leading the way in AI technology and one we have followed closely for a number of years. AI is a buzz word in our sector at the moment and we are very excited about working with MVision to integrate their leading technology into Radiotherapy departments in the UK and Irelandâ€, said Jack Knight , Managing Director, Xiel Ltd This has a high impact on RT treatment because, according to Cancer Research UK , the time between the urgent referral and treatment process can take up to 62 days. Thanks to Xiel's distribution of MVision AI's segmentation software, oncologists will be able to receive consistent, cancer radiotherapy treatment planning. MVision's cutting-edge, segmentation solutions can help improve the efficiency of cancer patient's radiotherapy. MVsion's CEO and co-founder, Mahmudul Hasan, highlighted his delight in this new partnership, stating that, \"We have been working on MVision's state-of-the-art segmentation services for the last three years. A growing number of hospitals have incorporated our services into their radiation oncology departments. Radiation oncologists have found our solutions to be essential, while improving the speed of service to their patients. We look forward to doing the same for UK patients, as our breakthrough solution reaches the UK and Ireland with the help of Xiel.†If you are interested in learning more about Xiel's impactful distribution, check out their informative, company website and professional LinkedIn profile . For more information on our services, contact MVision AI c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland. Tel: +358 (0) 40 5489 229 Email: info (at) mvision.ai +358 40 500 7915; pr (at) mvision.ai",
    "Guideline-Based Segmentation for High Precision Radiotherapy DISCOVER GBSâ\"¢ Schedule a demo Dose+ AI-Guided Plan Optimisation Dose+ is an AI-powered dose prediction software designed to assist radiation therapy professionals in treatment planning. Initially validated for prostate and pelvic lymph node cases, Dose+ provides patient-specific dose predictions to facilitate and speed-up plan optimisation. By using advanced machine learning techniques, it helps to decrease manual interactions during the inverse planning without compromising plan quality. Dose+ integrates with all DICOM-compliant treatment planning systems, allowing for immediate clinical use without disrupting workflows. Discover Dose+ GBSâ\"¢ solution Guideline-Based Segmentation Suite for Radiotherapy GBSâ\"¢ is a game-changing innovation that brings together three powerful tools essential for efficient and effective radiotherapy—Contour+, an AI-powered auto-contouring software; Verify, a contour assessment tool; and Guide, a guideline training environment. GBSâ\"¢ empowers radiation oncology professionals to create precise, guideline-compliant contours in a fraction of the time and equips them with the tools to enhance their contouring skills and guideline know-how. This comprehensive approach results in optimized treatment plans delivered with unparalleled efficiency. Discover GBSâ\"¢ GBSâ\"¢ products Contour+ AI-powered auto-contouring software that generates reliable and consistent contours in a fraction of the time. Guide Training environment designed to help practitioners gain guideline expertise, refine and assess their contouring proficiency. Verify Contour comparison tool that allows users to analyze structures from multiple sources and gain clarity on contour accuracy. Contour+ AI-Powered Auto-Contouring Contour+ is an AI-powered software that generates fast and precise automatic delineation of organs-at-risk and lymph node areas. By following industry best practices, Contour+ ensures standardized and consistent contours, enabling clinicians to deliver high-quality treatment plans more efficiently. Discover Contour+ Standardized Contouring Models trained with peer-reviewed contouring data according to 25+ consensus guidelines. Increased Accuracy Accurate, fast and reliable contours of 300+ ROIs, including 90 lymph node areas. Efficient Workflow A reduction of up to 95% in contouring time per patient. Seamless Integration Cloud-based and local, fully compatible with all radiotherapy treatment planning systems. Strong Return On Investment Significantly reduces contouring time which leads to substantial cost savings.* * Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation why mvision ai Transforming Cancer Care Worldwide GBSâ\"¢ is trusted by leading clinics worldwide, treating over 190,000 cancer patients annually across 20 countries. At the heart of our innovation are the people who rely on our solutions daily—radiation oncologists, therapists, medical physicists, and clinical scientists. Their expertise shapes every product we create. By reducing treatment times for every patient, we aim to improve outcomes and enhance the quality of life for cancer patients. Our ultimate goal? To make same-day treatment a reality. about us Using Guide to prepare staff for AI contouring and to train for comprehensive contouring practice, we've observed significant enhancements in overall contour precision within a short timeframe. Mihály Simon Medical Physicist, Clinic of Oncoradiology University of Debrecen Debrecen, Hungary We have imaged and treated our prostate cancer patients during the same day with the help of MVisionAI's auto-segmentation. Now we can schedule for shorter waiting times with more confidence. Timo Kiljunen Adjunct Professor and Medical Physicist Docrates Cancer Center Helsinki, Finland I am a perfectionist and I treat patients with highly conformal techniques, so I really need accurate contours. In my opinion, MVision AI is one year ahead of what I have seen until now. In of quality, I would rate it 10 out of 10. Dr. Giuseppe Sasso Radiation Oncologist Te Toka Tumai Hospital Auckland, New Zealand We have a great improvement of our clinical workflow. We have gained one day just using MVision AI, we don't need any more staff, it was four hours of work to contour, now it is ten minutes. Dr sc. Marc Pachoud Riviera Chablais Hospital 100,000 handled scans globally 50,000 scans processed in the past 12 months News Press Releases , News MVision AI Working on Agreement to Offer Contour+ Accessâ\"¢ with Philips CT Simulators 28.09.25 Press Releases , News MVision AI Founder Mahmudul Hasan Returns as CEO to Lead Next Phase of Growth 23.09.25 Coming events Join us at Astro 2025 September 28 – 30, 2025 San Francisco, USA Booth #509 Guideline-Based Segmentation for High Precision Radiotherapy DISCOVER GBSâ\"¢ Schedule a demo Dose+ AI-Guided Plan Optimisation Dose+ is an AI-powered dose prediction software designed to assist radiation therapy professionals in treatment planning. Initially validated for prostate and pelvic lymph node cases, Dose+ provides patient-specific dose predictions to facilitate and speed-up plan optimisation. By using advanced machine learning techniques, it helps to decrease manual interactions during the inverse planning without compromising plan quality. Dose+ integrates with all DICOM-compliant treatment planning systems, allowing for immediate clinical use without disrupting workflows. Discover Dose+ Dose+ is an AI-powered dose prediction software designed to assist radiation therapy professionals in treatment planning. Initially validated for prostate and pelvic lymph node cases, Dose+ provides patient-specific dose predictions to facilitate and speed-up plan optimisation. By using advanced machine learning techniques, it helps to decrease manual interactions during the inverse planning without compromising plan quality. Dose+ integrates with all DICOM-compliant treatment planning systems, allowing for immediate clinical use without disrupting workflows. GBSâ\"¢ solution Guideline-Based Segmentation Suite for Radiotherapy GBSâ\"¢ is a game-changing innovation that brings together three powerful tools essential for efficient and effective radiotherapy—Contour+, an AI-powered auto-contouring software; Verify, a contour assessment tool; and Guide, a guideline training environment. GBSâ\"¢ empowers radiation oncology professionals to create precise, guideline-compliant contours in a fraction of the time and equips them with the tools to enhance their contouring skills and guideline know-how. This comprehensive approach results in optimized treatment plans delivered with unparalleled efficiency. Discover GBSâ\"¢ Guideline-Based Segmentation Suite for Radiotherapy GBSâ\"¢ is a game-changing innovation that brings together three powerful tools essential for efficient and effective radiotherapy—Contour+, an AI-powered auto-contouring software; Verify, a contour assessment tool; and Guide, a guideline training environment. GBSâ\"¢ empowers radiation oncology professionals to create precise, guideline-compliant contours in a fraction of the time and equips them with the tools to enhance their contouring skills and guideline know-how. This comprehensive approach results in optimized treatment plans delivered with unparalleled efficiency. Contour+ AI-powered auto-contouring software that generates reliable and consistent contours in a fraction of the time. Guide Training environment designed to help practitioners gain guideline expertise, refine and assess their contouring proficiency. Verify Contour comparison tool that allows users to analyze structures from multiple sources and gain clarity on contour accuracy. AI-powered auto-contouring software that generates reliable and consistent contours in a fraction of the time. Training environment designed to help practitioners gain guideline expertise, refine and assess their contouring proficiency. Contour comparison tool that allows users to analyze structures from multiple sources and gain clarity on contour accuracy. Contour+ AI-Powered Auto-Contouring Contour+ is an AI-powered software that generates fast and precise automatic delineation of organs-at-risk and lymph node areas. By following industry best practices, Contour+ ensures standardized and consistent contours, enabling clinicians to deliver high-quality treatment plans more efficiently. Discover Contour+ Standardized Contouring Models trained with peer-reviewed contouring data according to 25+ consensus guidelines. Increased Accuracy Accurate, fast and reliable contours of 300+ ROIs, including 90 lymph node areas. Efficient Workflow A reduction of up to 95% in contouring time per patient. Seamless Integration Cloud-based and local, fully compatible with all radiotherapy treatment planning systems. Strong Return On Investment Significantly reduces contouring time which leads to substantial cost savings.* * Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation Contour+ is an AI-powered software that generates fast and precise automatic delineation of organs-at-risk and lymph node areas. By following industry best practices, Contour+ ensures standardized and consistent contours, enabling clinicians to deliver high-quality treatment plans more efficiently. Models trained with peer-reviewed contouring data according to 25+ consensus guidelines. Accurate, fast and reliable contours of 300+ ROIs, including 90 lymph node areas. A reduction of up to 95% in contouring time per patient. Cloud-based and local, fully compatible with all radiotherapy treatment planning systems. Significantly reduces contouring time which leads to substantial cost savings.* * Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation why mvision ai Transforming Cancer Care Worldwide GBSâ\"¢ is trusted by leading clinics worldwide, treating over 190,000 cancer patients annually across 20 countries. At the heart of our innovation are the people who rely on our solutions daily—radiation oncologists, therapists, medical physicists, and clinical scientists. Their expertise shapes every product we create. By reducing treatment times for every patient, we aim to improve outcomes and enhance the quality of life for cancer patients. Our ultimate goal? To make same-day treatment a reality. about us Transforming Cancer Care Worldwide GBSâ\"¢ is trusted by leading clinics worldwide, treating over 190,000 cancer patients annually across 20 countries. At the heart of our innovation are the people who rely on our solutions daily—radiation oncologists, therapists, medical physicists, and clinical scientists. Their expertise shapes every product we create. By reducing treatment times for every patient, we aim to improve outcomes and enhance the quality of life for cancer patients. Our ultimate goal? To make same-day treatment a reality. Using Guide to prepare staff for AI contouring and to train for comprehensive contouring practice, we've observed significant enhancements in overall contour precision within a short timeframe. Mihály Simon Medical Physicist, Clinic of Oncoradiology University of Debrecen Debrecen, Hungary We have imaged and treated our prostate cancer patients during the same day with the help of MVisionAI's auto-segmentation. Now we can schedule for shorter waiting times with more confidence. Timo Kiljunen Adjunct Professor and Medical Physicist Docrates Cancer Center Helsinki, Finland I am a perfectionist and I treat patients with highly conformal techniques, so I really need accurate contours. In my opinion, MVision AI is one year ahead of what I have seen until now. In of quality, I would rate it 10 out of 10. Dr. Giuseppe Sasso Radiation Oncologist Te Toka Tumai Hospital Auckland, New Zealand We have a great improvement of our clinical workflow. We have gained one day just using MVision AI, we don't need any more staff, it was four hours of work to contour, now it is ten minutes. Dr sc. Marc Pachoud Riviera Chablais Hospital 100,000 handled scans globally 50,000 scans processed in the past 12 months Using Guide to prepare staff for AI contouring and to train for comprehensive contouring practice, we've observed significant enhancements in overall contour precision within a short timeframe. Mihály Simon Medical Physicist, Clinic of Oncoradiology University of Debrecen Debrecen, Hungary Using Guide to prepare staff for AI contouring and to train for comprehensive contouring practice, we've observed significant enhancements in overall contour precision within a short timeframe. We have imaged and treated our prostate cancer patients during the same day with the help of MVisionAI's auto-segmentation. Now we can schedule for shorter waiting times with more confidence. Timo Kiljunen Adjunct Professor and Medical Physicist Docrates Cancer Center Helsinki, Finland We have imaged and treated our prostate cancer patients during the same day with the help of MVisionAI's auto-segmentation. Now we can schedule for shorter waiting times with more confidence. I am a perfectionist and I treat patients with highly conformal techniques, so I really need accurate contours. In my opinion, MVision AI is one year ahead of what I have seen until now. In of quality, I would rate it 10 out of 10. Dr. Giuseppe Sasso Radiation Oncologist Te Toka Tumai Hospital Auckland, New Zealand I am a perfectionist and I treat patients with highly conformal techniques, so I really need accurate contours. In my opinion, MVision AI is one year ahead of what I have seen until now. In of quality, I would rate it 10 out of 10. We have a great improvement of our clinical workflow. We have gained one day just using MVision AI, we don't need any more staff, it was four hours of work to contour, now it is ten minutes. Dr sc. Marc Pachoud Riviera Chablais Hospital We have a great improvement of our clinical workflow. We have gained one day just using MVision AI, we don't need any more staff, it was four hours of work to contour, now it is ten minutes. News Press Releases , News MVision AI Working on Agreement to Offer Contour+ Accessâ\"¢ with Philips CT Simulators 28.09.25 Press Releases , News MVision AI Founder Mahmudul Hasan Returns as CEO to Lead Next Phase of Growth 23.09.25 Press Releases , News MVision AI Working on Agreement to Offer Contour+ Accessâ\"¢ with Philips CT Simulators 28.09.25 MVision AI Working on Agreement to Offer Contour+ Accessâ\"¢ with Philips CT Simulators Press Releases , News MVision AI Founder Mahmudul Hasan Returns as CEO to Lead Next Phase of Growth 23.09.25 MVision AI Founder Mahmudul Hasan Returns as CEO to Lead Next Phase of Growth Coming events Join us at Astro 2025 September 28 – 30, 2025 San Francisco, USA Booth #509 Join us at Astro 2025 September 28 – 30, 2025 San Francisco, USA Booth #509 September 28 – 30, 2025 San Francisco, USA Booth #509",
    "YourRad AB is Providing MVision's AI-Powered Segmentation Service to Nordic Cancer Hospitals 5.11.21 Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in the Nordic region. YourRad AB and MVision AI are devoted to accelerated, prime, and guideline-based provisions of radiotherapy solutions for Nordic radiation oncology practices. The MVision AI team will collaborate with YourRad staff to assure the dispensation of superior, swift, and dependable radiotherapy services. \"We are happy and proud of the partnership with MVISION Oy. The feedback from our end users in radiotherapy have been excellent. It mainly highlights the fact that the quality and consistency are excellent and that the value for both health care professionals and patients is great. Very high quality in delineating OAR´s and time saving are the key benefits according to customers,†says M. Forss, CEO of YourRad AB. As stated by Mahmudul Hasan, CEO, and co-founder of MVision AI, \"MVision is delighted to partner with YourRad AB to bring our guideline-based AI segmentation (GBAISâ\"¢ and GCAISâ\"¢) to Nordic customers. Nordic countries have always been at the forefront of adopting cutting-edge technologies. MVision is excited to bring more innovative solutions to facilitate same-day treatment as a reality.†For additional information on YourRad AB: Magasinsgatan 8C, 434 37, Kungsbacka, Sweden Tel: +46 (0) 70 609 88 91 Email: info@yourrad.se LinkedIn: https://www.linkedin.com/company/yourrad-ab/?originalSubdomain=se For supplementary information on MVision AI: c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland. Tel: +358 (0) 40 5489 229 Website : https://www.mvision.ai Email: info@mvision.ai Social Media: Facebook, Instagram, LinkedIn , Twitter, and Youtube For media inquiries: Tel: +358 40 500 7915 Email: pr@mvision.ai Prev The Current State of Cancer Care and Radiotherapy in the US Next Examining the Capacity of Radiotherapy to Treat Lung Cancer YourRad AB is Providing MVision's AI-Powered Segmentation Service to Nordic Cancer Hospitals 5.11.21 Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in the Nordic region. YourRad AB and MVision AI are devoted to accelerated, prime, and guideline-based provisions of radiotherapy solutions for Nordic radiation oncology practices. The MVision AI team will collaborate with YourRad staff to assure the dispensation of superior, swift, and dependable radiotherapy services. \"We are happy and proud of the partnership with MVISION Oy. The feedback from our end users in radiotherapy have been excellent. It mainly highlights the fact that the quality and consistency are excellent and that the value for both health care professionals and patients is great. Very high quality in delineating OAR´s and time saving are the key benefits according to customers,†says M. Forss, CEO of YourRad AB. As stated by Mahmudul Hasan, CEO, and co-founder of MVision AI, \"MVision is delighted to partner with YourRad AB to bring our guideline-based AI segmentation (GBAISâ\"¢ and GCAISâ\"¢) to Nordic customers. Nordic countries have always been at the forefront of adopting cutting-edge technologies. MVision is excited to bring more innovative solutions to facilitate same-day treatment as a reality.†For additional information on YourRad AB: Magasinsgatan 8C, 434 37, Kungsbacka, Sweden Tel: +46 (0) 70 609 88 91 Email: info@yourrad.se LinkedIn: https://www.linkedin.com/company/yourrad-ab/?originalSubdomain=se For supplementary information on MVision AI: c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland. Tel: +358 (0) 40 5489 229 Website : https://www.mvision.ai Email: info@mvision.ai Social Media: Facebook, Instagram, LinkedIn , Twitter, and Youtube For media inquiries: Tel: +358 40 500 7915 Email: pr@mvision.ai Prev The Current State of Cancer Care and Radiotherapy in the US Next Examining the Capacity of Radiotherapy to Treat Lung Cancer YourRad AB is Providing MVision's AI-Powered Segmentation Service to Nordic Cancer Hospitals Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in the Nordic region. YourRad AB and MVision AI are devoted to accelerated, prime, and guideline-based provisions of radiotherapy solutions for Nordic radiation oncology practices. The MVision AI team will collaborate with YourRad staff to assure the dispensation of superior, swift, and dependable radiotherapy services. \"We are happy and proud of the partnership with MVISION Oy. The feedback from our end users in radiotherapy have been excellent. It mainly highlights the fact that the quality and consistency are excellent and that the value for both health care professionals and patients is great. Very high quality in delineating OAR´s and time saving are the key benefits according to customers,†says M. Forss, CEO of YourRad AB. As stated by Mahmudul Hasan, CEO, and co-founder of MVision AI, \"MVision is delighted to partner with YourRad AB to bring our guideline-based AI segmentation (GBAISâ\"¢ and GCAISâ\"¢) to Nordic customers. Nordic countries have always been at the forefront of adopting cutting-edge technologies. MVision is excited to bring more innovative solutions to facilitate same-day treatment as a reality.†For additional information on YourRad AB: Magasinsgatan 8C, 434 37, Kungsbacka, Sweden Tel: +46 (0) 70 609 88 91 For supplementary information on MVision AI: c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland. Tel: +358 (0) 40 5489 229 Social Media: Facebook, Instagram, LinkedIn , Twitter, and Youtube Tel: +358 40 500 7915"
  ]
}